HKMPY (Hikma Pharmaceuticals) Purchase Of Investment : $-2 Mil (TTM As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Hikma Pharmaceuticals Purchase Of Investment?

Hikma Pharmaceuticals's purchase of investment for the six months ended in Dec. 2024 was $0 Mil. It means Hikma Pharmaceuticals spent $0 Mil on purchasing investments. Hikma Pharmaceuticals's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2024 was $-2 Mil.

Compared with last quarter ($-2 Mil in Jun. 2024 ), Hikma Pharmaceuticals spent less money on purchasing investments in Dec. 2024 ($0 Mil).

Hikma Pharmaceuticals Purchase Of Investment Historical Data

The historical data trend for Hikma Pharmaceuticals's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikma Pharmaceuticals Purchase Of Investment Chart

Hikma Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Purchase Of Investment

Get a 7-Day Free Trial

-5.00

-3.00

-15.00

-27.00

-2.00

Hikma Pharmaceuticals Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Purchase Of Investment	Get a 7-Day Free Trial															-1.00	-5.00	-22.00	-2.00	-

Hikma Pharmaceuticals Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-2 Mil.

Hikma Pharmaceuticals Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Hikma Pharmaceuticals's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Hikma Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (OTCPK:HKMPY) » Definitions » Purchase Of Investment

Comparable Companies

Traded in Other Exchanges

HKMPF:USA HIKl:UK HIK:UK H5P:Germany

Address

1 New Burlington Place, London, GBR, W1S 2HR

Website

https://www.hikma.com

Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.